» Articles » PMID: 35331113

Nanostructured Lipid Carriers for the Delivery of Natural Bioactive Compounds

Overview
Journal Curr Drug Deliv
Specialty Pharmacology
Date 2022 Mar 25
PMID 35331113
Authors
Affiliations
Soon will be listed here.
Abstract

Natural products contain bioactive compounds that are produced naturally via synthetic or semisynthetic processes. These bioactive compounds play significant biological roles, especially for growth as well as in defense mechanisms against pathogens. Bioactive compounds in natural products have been extensively studied in recent decades for their pharmacological activities, such as anticancer, wound healing, anti-microbial, anti-inflammatory, and anti-oxidative properties. However, their pharmaceutical significance has always been hindered by their low bioavailability and instability with variations in pH, temperature, and exposure to light. Nanotechnology paves the way for the development of drug delivery systems by enhancing therapeutic efficacy. Nanostructured lipid carriers, a lipidbased drug delivery system, are recently being studied to improve the biocompatibility, biodegradability, bioavailability, solubility, permeability, and shelf life of bioactive compounds in the pharmaceutical industry. The ideal component and preparation method for bioactive compounds in nanostructured lipid carrier development is necessary for their physicochemical properties and therapeutic efficiency. Therefore, this review seeks to highlight recent developments, preparation, and application of nanostructured lipid carriers as carriers for natural bioactive compounds in improving their therapeutic potential in drug delivery systems.

Citing Articles

Macrocycle-Based Supramolecular Drug Delivery Systems: A Concise Review.

Yang Y, Li P, Feng H, Zeng R, Li S, Zhang Q Molecules. 2024; 29(16).

PMID: 39202907 PMC: 11357536. DOI: 10.3390/molecules29163828.


Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment-A Recent Review.

Arafat M, Sakkal M, Beiram R, AbuRuz S Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543101 PMC: 10974155. DOI: 10.3390/ph17030315.


Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges.

Rahman M, Afzal O, Najib Ullah S, Alshahrani M, Alkhathami A, Altamimi A ACS Omega. 2024; 8(51):48625-48649.

PMID: 38162753 PMC: 10753706. DOI: 10.1021/acsomega.3c07345.


Enhancing Skin Delivery and Stability of Vanillic and Ferulic Acids in Aqueous Enzymatically Extracted Glutinous Rice Husk by Nanostructured Lipid Carriers.

Jiamphun S, Chaiyana W Pharmaceutics. 2023; 15(7).

PMID: 37514147 PMC: 10384697. DOI: 10.3390/pharmaceutics15071961.


Recent Progress in Nanotechnology Improving the Therapeutic Potential of Polyphenols for Cancer.

Vieira I, Tessaro L, Lima A, Velloso I, Conte-Junior C Nutrients. 2023; 15(14).

PMID: 37513554 PMC: 10384266. DOI: 10.3390/nu15143136.